Quipt Home Medical (TSE:QIPT – Free Report) had its target price decreased by Stifel Nicolaus from C$8.40 to C$7.50 in a report released on Thursday morning,BayStreet.CA reports. Stifel Nicolaus currently has a buy rating on the stock.
Quipt Home Medical Trading Up 3.8 %
Shares of TSE:QIPT opened at C$3.56 on Thursday. Quipt Home Medical has a 12-month low of C$3.28 and a 12-month high of C$6.98. The company has a market cap of C$153.40 million, a PE ratio of -20.88 and a beta of 1.01. The stock has a 50 day moving average of C$3.72 and a 200 day moving average of C$4.14.
About Quipt Home Medical
See Also
- Five stocks we like better than Quipt Home Medical
- What is the Australian Securities Exchange (ASX)
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Insider Trades May Not Tell You What You Think
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.